Integrated, Real-Time Decision Making

Total Page:16

File Type:pdf, Size:1020Kb

Integrated, Real-Time Decision Making Integrated, Real-Time Decision Making: A Prescription for Improving Patient Outcomes and Your Bottom Line April 2011 Business White Paper White Business COntents INTRODUCTION 3 TODAY’S REALITY 4 THE PATH TO INTEGRATION 5 REAL-WORLD SUCCESSES 7 MEETING SPECIFIC CHALLENGES 9 WHERE TO BEGIN 11 2 WHITE PAPER | Real-TImE Integration INTRODUCTION Almost universally, hospital executives state their mission this way: “Deliver the best possible care for patients while being fiscally responsible.” To achieve this goal they must resolve what is sometimes seen as the tension between optimal patient care and costs. And when in doubt they usually and understandably err on the side of patient care. As a result, many hospitals have succumbed to the “build it and they will come” syndrome. In the laudable desire to ensure that no detail is overlooked they proliferate systems and processes. But because these systems and processes have grown tactically rather than strategically they often remain unintegrated, highly specialized and inflexible. The inability of these disparate systems to consolidate and share data can lead to the very problems of patient care they are intended to prevent – and the ballooning of costs they should help to control. Experience in numerous industries, including healthcare, has shown that integrated business and data systems lead to greater effectiveness and greater efficiency. Such a proven set of Experience in numerous capabilities forms the basis of the majority of financial transactions in the United States. industries, including healthcare, According to a leading market research firm, more than half of leading process-centric has shown that integrated companies and more than one-third of the top 25 process-centric healthcare companies use business and data systems lead such capabilities to provide the end-to-end process visibility required to cost-effectively deliver to greater effectiveness and superior service. greater efficiency. To help you explore the potential of these capabilities for healthcare organizations, this white paper will: • Examine the reality of unintegrated processes and data in healthcare settings • Describe a set of proven tools for achieving integration • Offer real-world examples of healthcare organizations that are applying these tools to affect patient outcomes and control costs • Identify proven approaches to six specific and highly critical challenges for healthcare organizations • Suggest what you can do to begin achieving enterprise integration and real-time decision-making WHITE PAPER | Real-TImE Integration 3 TODAY’S REALITY Hospitals today face a variety of demanding requirements and business imperatives. They need to: • Acquire more patients and avoid losing patients. • Adhere to applicable federal, state and payor requirements without adding extra work to already highly utilized staff. This is a moving target for healthcare institutions. For example, since 2005 the Centers for Medicare and Medicaid Services require reporting on 10 metrics. In 2010 the number increased to 72 metrics. And, most recently, healthcare institutions must address the specifications around “Meaningful Use” tests and reporting to qualify for government funding. • Eliminate adverse events and reduce patient wait times. Today, adverse events are the fourth leading cause of death in the U.S.– mostly around administered drugs. Across the U.S. today, 50 percent of patients don’t get the proper care whether it be preventative, acute or chronic. This might soon be a reportable metric that the industry will be judged on. • Attract best possible staff and increase patient referrals. Unfortunately, numerous obstacles hinder many institutions from fully realizing these goals. These obstacles include siloed systems with little or no integration among them, and complex IT infrastructures that are often hard-wired, proprietary, and outdated. These systems are the result not only of sub-optimal technological approaches but also of political and economic forces. They result in unwieldy processes that alienate patients, contribute to adverse events, and lag behind evolving business requirements. the Burden of Integration There are many nodes of information in healthcare institutions: clinical systems, administrative systems, PACS system, monitoring databases, diagnostic repositories, drug information systems, external systems, and more. However, due to the lack of integration the data in Without the proper information these systems is not contextualized in a way that provides information that can be used by at the proper time, caregivers caregivers. Often, the burden of integration falls on the individual caregiver at the point of must make decisions based on care, or what we call ‘the patient-based moment of truth.’ Without the proper information at experience, not on information. the proper time, caregivers must make decisions based on experience, not on information. These decisions are not just mission-critical, but can also be matters of life and death. Process Complexity Consider a typical business process within a healthcare institution, whether it’s patient admittance from the time they come through the ER to the time they are moved into a room, or any of many other processes. Typically, these processes are quite complex, consisting of many steps that can occur sequentially or sometimes concurrently. A single business process can actually span many departments, service lines, and political boundaries within an institution. These additional layers of complexity can make it difficult to ensure smooth hand-offs and efficient processing, and can hinder the ability to pinpoint the bottlenecks. In fact, when a well-known major consulting firm was hired to map the processes for NASA and highlight problems the project took less than one year. The same consulting firm worked for two years on mapping the processes at a major healthcare provider and gave up. 4 WHITE PAPER | Real-TImE Integration THE PATH TO INTEGRATION You can cut through the complexity and achieve visibility of your processes and business within your institution and across your external partners by moving to a much more flexible IT architecture. Unfortunately, today there are few interconnected systems, and those that are interconnected typically use point-to-point interfaces that require pervasive modifications to accommodate changes to business requirements, making it difficult to comply with evolving mandates. Users must navigate through multiple functional systems to perform a single task. They may have 20 percent of data at their fingertips and then need to get the other 80 percent from other systems. The individual systems don’t communicate easily across func- tional, political, or technical boundaries, which makes it difficult to share information or reuse functionality. service-Oriented Architecture Often the first step in moving from point-to-point data collection to an integrated enterprise is Often the first step in moving to integrate existing data, eventually evolving to the integration of business and clinical from point-to-point data functions. This is the path to Service-Oriented Architecture or SOA. collection to an integrated enterprise is to integrate existing data, eventually SOA provides the flexible information architecture required to decouple business functions evolving to the integration of from hardwired, monolithic legacy applications. Application components or “services” are well business and clinical functions. defined using common interfaces; they utilize a contract to define how services will be invoked, and they interact in a loosely coupled manner. In this environment, the terms “client” and “server” are purely situational. At one moment, an application could act as a client by calling an external service, while moments later, it may act as a service-provider when called by another application to perform a task. When properly implemented, SOA ends the building and maintenance of point-to-point integrations. Using SOA, you can generate new services in a flexible and agile way by combining existing logic and exposing it via reusable services. Once your core business functions have been exposed as services, they can be integrated across organizational boundaries. These loosely coupled services provide you with the ability to respond to changing requirements because of the layer of abstraction that SOA provides between the services and the underlying technology. Meanwhile, SOA governance tools ensure that services and other assets within the SOA continually meet established expecta- tions for security, performance, quality, and reliability. WHITE PAPER | Real-TImE Integration 5 supporting Process Improvement Achieving enterprise integration is just the first step. You still need to address the issue of multiple systems and interfaces to perform a single business function. In other words, you need a way to simplify execution of single tasks and enable integration across functional and technical boundaries. You have no choice but to deal with such business processes. However, you do have a choice of how to improve and manage them. You can implement them through passive technological osmosis that leads to a patchwork of processes that are imperfectly pieced together with point solutions, manual labor, and expensive ERP systems. Or you can employ a reasoned, disci- plined, and innovative approach that confers significant competitive advantages. Using Business Process That’s where Healthcare Process Automation comes into play.
Recommended publications
  • Full Portfolio Holdings
    Hartford Multifactor International Fund Full Portfolio Holdings* as of August 31, 2021 % of Security Coupon Maturity Shares/Par Market Value Net Assets Merck KGaA 0.000 152 36,115 0.982 Kuehne + Nagel International AG 0.000 96 35,085 0.954 Novo Nordisk A/S 0.000 333 33,337 0.906 Koninklijke Ahold Delhaize N.V. 0.000 938 31,646 0.860 Investor AB 0.000 1,268 30,329 0.824 Roche Holding AG 0.000 74 29,715 0.808 WM Morrison Supermarkets plc 0.000 6,781 26,972 0.733 Wesfarmers Ltd. 0.000 577 25,201 0.685 Bouygues S.A. 0.000 595 24,915 0.677 Swisscom AG 0.000 42 24,651 0.670 Loblaw Cos., Ltd. 0.000 347 24,448 0.665 Mineral Resources Ltd. 0.000 596 23,709 0.644 Royal Bank of Canada 0.000 228 23,421 0.637 Bridgestone Corp. 0.000 500 23,017 0.626 BlueScope Steel Ltd. 0.000 1,255 22,944 0.624 Yangzijiang Shipbuilding Holdings Ltd. 0.000 18,600 22,650 0.616 BCE, Inc. 0.000 427 22,270 0.605 Fortescue Metals Group Ltd. 0.000 1,440 21,953 0.597 NN Group N.V. 0.000 411 21,320 0.579 Electricite de France S.A. 0.000 1,560 21,157 0.575 Royal Mail plc 0.000 3,051 20,780 0.565 Sonic Healthcare Ltd. 0.000 643 20,357 0.553 Rio Tinto plc 0.000 271 20,050 0.545 Coloplast A/S 0.000 113 19,578 0.532 Admiral Group plc 0.000 394 19,576 0.532 Swiss Life Holding AG 0.000 37 19,285 0.524 Dexus 0.000 2,432 18,926 0.514 Kesko Oyj 0.000 457 18,910 0.514 Woolworths Group Ltd.
    [Show full text]
  • Retirement Strategy Fund 2060 Description Plan 3S DCP & JRA
    Retirement Strategy Fund 2060 June 30, 2020 Note: Numbers may not always add up due to rounding. % Invested For Each Plan Description Plan 3s DCP & JRA ACTIVIA PROPERTIES INC REIT 0.0137% 0.0137% AEON REIT INVESTMENT CORP REIT 0.0195% 0.0195% ALEXANDER + BALDWIN INC REIT 0.0118% 0.0118% ALEXANDRIA REAL ESTATE EQUIT REIT USD.01 0.0585% 0.0585% ALLIANCEBERNSTEIN GOVT STIF SSC FUND 64BA AGIS 587 0.0329% 0.0329% ALLIED PROPERTIES REAL ESTAT REIT 0.0219% 0.0219% AMERICAN CAMPUS COMMUNITIES REIT USD.01 0.0277% 0.0277% AMERICAN HOMES 4 RENT A REIT USD.01 0.0396% 0.0396% AMERICOLD REALTY TRUST REIT USD.01 0.0427% 0.0427% ARMADA HOFFLER PROPERTIES IN REIT USD.01 0.0124% 0.0124% AROUNDTOWN SA COMMON STOCK EUR.01 0.0248% 0.0248% ASSURA PLC REIT GBP.1 0.0319% 0.0319% AUSTRALIAN DOLLAR 0.0061% 0.0061% AZRIELI GROUP LTD COMMON STOCK ILS.1 0.0101% 0.0101% BLUEROCK RESIDENTIAL GROWTH REIT USD.01 0.0102% 0.0102% BOSTON PROPERTIES INC REIT USD.01 0.0580% 0.0580% BRAZILIAN REAL 0.0000% 0.0000% BRIXMOR PROPERTY GROUP INC REIT USD.01 0.0418% 0.0418% CA IMMOBILIEN ANLAGEN AG COMMON STOCK 0.0191% 0.0191% CAMDEN PROPERTY TRUST REIT USD.01 0.0394% 0.0394% CANADIAN DOLLAR 0.0005% 0.0005% CAPITALAND COMMERCIAL TRUST REIT 0.0228% 0.0228% CIFI HOLDINGS GROUP CO LTD COMMON STOCK HKD.1 0.0105% 0.0105% CITY DEVELOPMENTS LTD COMMON STOCK 0.0129% 0.0129% CK ASSET HOLDINGS LTD COMMON STOCK HKD1.0 0.0378% 0.0378% COMFORIA RESIDENTIAL REIT IN REIT 0.0328% 0.0328% COUSINS PROPERTIES INC REIT USD1.0 0.0403% 0.0403% CUBESMART REIT USD.01 0.0359% 0.0359% DAIWA OFFICE INVESTMENT
    [Show full text]
  • 27 November 2019 Frankfurt / Main Programme Overview and Floor Plans
    DEUTSCHE BÖRSE CASH MARKET Deutsches Eigenkapitalforum 25 – 27 November 2019 Frankfurt / Main Programme overview and floor plans Platinum Partners Gold Partners Silver Partners A Stifel Company Media Partners Further supporters BankM, Better Orange, CMS Hasche Sigle, GBC, Heuking Kühn Lüer Wojtek, Kirchhoff Consult, Mediaplanet, Pinsent Masons, viaprinto Monday, 25 November 2019 09:00 Morning coffee Networking and opportunity to visit the exhibition Plenary session I – Main stage 09:30 Welcome address and opening remarks * Hauke Stars, Executive Board, Dr Ingrid Hengster, Executive Board, Deutsche Börse AG KfW Bankengruppe 10:00 Keynote speech: “The cold trade war and the consequences” * The trade war between the USA and China could develop into an ongoing conflict for the coming decade Speaker: Dr Jörg Krämer characterized similar to the Cold War which followed forty years after the Second World War. We are con- Chief Economist fronted with de-globalisation of the world economy. Dr. Jörg Krämer will elaborate how companies in this Commerzbank AG environment are affected and what implications this could have for central banks and financial markets. Analysts’ conferences I Room London Madrid Milan Oslo Paris Zurich Sector Financial services Technology Telecommunications Biotech / Medtech Industrial goods & services Chemicals 10:30 JDC Group AG EQS Group AG 11880 Solutions AG* Merck KGaA GESCO AG K+S AG 11:00 creditshelf AG FACC AG NFON AG MorphoSys AG* Daldrup & Söhne AG* Wacker Chemie AG 11:30 DFV Deutsche Familien- PNE AG* Mynaric AG Evotec AG SMT Scharf AG* BRAIN AG versicherung AG* 12:00 Lunch Time for networking and opportunity to visit the exhibition Plenary session II – Main stage 13:00 Panel discussion: “Roadshows, 1-on-1s, business case: How to attract investors in current financial markets” * How does the investor relations team of a listed company communicate best with investors to attract them.
    [Show full text]
  • MDAX—2019 Supervisory Board Study Key Insights from This Year’S Analysis by Russell Reynolds Associates
    MDAX—2019 Supervisory Board Study Key insights from this year’s analysis by Russell Reynolds Associates Summary Over the past year, Germany's MDAX companies have experienced significant change. The number of companies in the index increased by 10, bringing the overall total to 60. Moreover, 11 "old economy" firms, including Jungheinrich, Krones, Leoni, Salzgitter and Schaeffler, were ousted by pharma, med and biotech risers, such as Evotec, Morphosys, Qiagen, Sartorius and Siemens Healthineers, as well as "new economy" powerhouses like Dialog, Nemetschek, Software AG, Telefonica D, and United Internet. This was also an exceptional election year, with 106 shareholder representative positions expiring. All positions were filled. A total of 67 board members were re-elected, while 36 were replaced. The three remaining roles were absorbed by changes to board sizes. Female shareholder representation surpasses 30 percent For the first time, the share of female shareholder representatives surpassed the required quota, reaching 30.6 percent. Including employee representatives, women now make up 32 percent of supervisory board members. A total of three boards are now chaired by women. However, there is still a major gender discrepancy concerning positions of power when comparing chairpersonships and especially executive board positions. Only four companies can boast more than 30 percent of female executives, while 40 MDAX companies do not have a single woman in a leadership role. Accelerated increase in digital directors The number of digital directors on MDAX supervisory boards showed a significant 30 percent year- on-year increase. However, digital expertise is still unevenly spread in the MDAX. Seven companies have three or more digital directors, while 57 percent of boards completely lack digital expertise.
    [Show full text]
  • Analyst's Conferences Tuesday, November 25, 2014
    Analyst's conferences Tuesday, November 25, 2014 Room London Sector Pharma / Biotech Time Company name Speaker 09:30-10:00 aap Implantate AG Bruke Seyoum Alemu, Chairman of the Management Board/CEO Marek Hahn, Member of the Management Board/CFO Sector Pharma / Biotech Time Company name Speaker 11:00-11:30 Eckert & Ziegler AG* Dr. Andreas Eckert, CEO Ron Littmann, CFO Sector Pharma / Biotech Time Company name Speakers 13:00-13:30 4SC AG Dipl. Kfm. Enno Spillner, CEO & CFO Jochen Orlowski, Head of Corporate Communications & Investor Relations 13:30-14:00 MorphoSys AG* Jens Holstein, Chief Financial Officer 14:00-14:30 Affimed N.V.* Dr. Adi Hoess, CEO Dr. Florian Fischer, CFO 14:30-15:00 PAION AG Dr Wolfgang Söhngen, CEO Abdelghani Omari, CFO 15:00-15:30 SYGNIS AG Pilar de la Huerta, CEO/CFO Michael Wolf, Vice President Finance & Accounting 15:30-16:00 Evotec AG Dr Werner Lanthaler, CEO 16:00-16:30 TRANSGENE Dr Hemanshu Shah, Vice President Medical Affairs PhD Elisabetta Castelli, Director Investor Relations 16:30-17:00 MOLOGEN AG Dr. Matthias Schroff, CEO 17:00-17:30 Medigene AG Peter Llewellyn-Davies, CFO 18:00-18:30 Santhera Pharmaceuticals Holding Ltd.* PhD Thomas Meier, CEO Dr. Roland Grimm, VP - Finance 18:30-19:00 Vita 34 AG* Dr. André Gerth, CEO Vita 34 Room Madrid Sector DAX / MDAX Time Company name Speakers 11:00-11:30 FUCHS PETROLUB SE Dr. Alexander Selent, Vice Chairman & CFO Dagmar Steinert, Head of Investor Relations 11:30-12:00 Axel Springer SE Claudia Thomé, Co-Head of Investor Relations Daniel Fard-Yazdani, Co- Head of Investor
    [Show full text]
  • FACTSHEET - AS of 28-Sep-2021 Solactive Mittelstand & Midcap Deutschland Index (TRN)
    FACTSHEET - AS OF 28-Sep-2021 Solactive Mittelstand & MidCap Deutschland Index (TRN) DESCRIPTION The Index reflects the net total return performance of 70 medium/smaller capitalisation companies incorporated in Germany. Weights are based on free float market capitalisation and are increased if significant holdings in a company can be attributed to currentmgmtor company founders. HISTORICAL PERFORMANCE 350 300 250 200 150 100 50 Jan-2010 Jan-2012 Jan-2014 Jan-2016 Jan-2018 Jan-2020 Jan-2022 Solactive Mittelstand & MidCap Deutschland Index (TRN) CHARACTERISTICS ISIN / WKN DE000SLA1MN9 / SLA1MN Base Value / Base Date 100 Points / 19.09.2008 Bloomberg / Reuters MTTLSTRN Index / .MTTLSTRN Last Price 342.52 Index Calculator Solactive AG Dividends Included (Performance Index) Index Type Equity Calculation 08:00am to 06:00pm (CET), every 15 seconds Index Currency EUR History Available daily back to 19.09.2008 Index Members 70 FACTSHEET - AS OF 28-Sep-2021 Solactive Mittelstand & MidCap Deutschland Index (TRN) STATISTICS 30D 90D 180D 360D YTD Since Inception Performance -3.69% 3.12% 7.26% 27.72% 12.73% 242.52% Performance (p.a.) - - - - - 9.91% Volatility (p.a.) 13.05% 12.12% 12.48% 13.60% 12.90% 21.43% High 357.49 357.49 357.49 357.49 357.49 357.49 Low 342.52 329.86 315.93 251.01 305.77 52.12 Sharpe Ratio -2.77 1.14 1.27 2.11 1.40 0.49 Max. Drawdown -4.19% -4.19% -4.19% -9.62% -5.56% -47.88% VaR 95 \ 99 -21.5% \ -35.8% -34.5% \ -64.0% CVaR 95 \ 99 -31.5% \ -46.8% -53.5% \ -89.0% COMPOSITION BY CURRENCIES COMPOSITION BY COUNTRIES EUR 100.0% DE
    [Show full text]
  • EXTEL 2018 Investor Relations Rankings for Germany
    EXTEL 2018 Investor Relations rankings for Germany June 2018 1. EXECUTIVE OVERVIEW & COMMENTARY This year marks the 13th Anniversary of the partnership between DIRK – Deutsche Investor Relations Verband - and Extel, an Institutional Investor Company. Every year, this successful collaboration produces the highly lauded Investor Relations Study, which takes its data from Extel’s comprehensive annual Pan-European Survey. The survey measures IR excellence and includes insightful views and trend information from investment professionals globally who are either invested in or cover the German equity market. The results of the study form the basis of the ‘Deutsche Investor Relations Preis’, presented during the DIRK annual conference in Frankfurt in June 2018. As part of its annual Pan-European Survey, year. The leading MDAX IR Professional Extel undertook this study from 14th March to was Burkhard Sawazki of LEG Immobilien 27th April, 2018; seeking ratings and rankings where 136 individuals received for IR excellence, at a company level and nominations. separately for IR professionals. From the In the SDAX category Hapag-Lloyd moved overall sector contributions, we derived up from 11th last year to 1st place. For the distinct rankings for the main German equity individual IR Professional ranking in SDAX, indices constituents – DAX30, MDAX, SDAX and Stephan Haas of SAF-HOLLAND was TecDAX. The study was undertaken almost ranked 1st, out of 61 individuals receiving exclusively through direct online votes. nominations. Telefonica Deutschland held on to top Since the beginning of the Extel and DIRK’s spot as the highly regarded TecDAX partnership in 2006, responses have increased company for IR.
    [Show full text]
  • SRO List EFDS Posting Feb 2019.Xlsx
    Significantly Regulated Organizations Added ‐ February 2019 DUNS TICKER BUSINESS NAME COUNTRY NAME EXCHANGE NAME NUMBER SYMBOL 220117440 MEDAPHOR GROUP PLC WALES MED London Stock Exchange (LON) 555278141 CAI LAY VETERINARY PHARMACY JOINT STOCK COMPANY VIETNAM MKV Hanoi Stock Exchange 555295156 CAN THO MINERAL AND CEMENT JOINT STOCK COMPANY VIETNAM CCM Hanoi Stock Exchange 555519774 CENTRAL PETROCHEMICAL AND FERTILIZER JOINT STOCK COMPANY VIETNAM PCE Hanoi Stock Exchange 555537308 HIEP KHANH TEA JOINT‐STOCK COMPANY VIETNAM HKT Hanoi Stock Exchange 555530218 HVA INVESTMENT JOINT STOCK COMPANY VIETNAM HVA Hanoi Stock Exchange 555242481 KIM VI INOX IMPORT EXPORT PRODUCTION JOINT STOCK COMPANY VIETNAM KVC Hanoi Stock Exchange 555322911 LILAMA 45.4 JOINT ‐ STOCK COMPANY VIETNAM L44 Hanoi Stock Exchange 555242771 MY XUAN BRICK TILE POTTERY AND CONSTRUCTION JOINT STOCK COMPANY VIETNAM GMX Hanoi Stock Exchange 555319545 NGAN SON JOINT STOCK COMPANY VIETNAM NST Hanoi Stock Exchange 555399648 NHA BE WATER SUPPLY JOINT STOCK COMPANY VIETNAM NBW Hanoi Stock Exchange 555290113 PETROVIETNAM TECHNICAL SERVICES CORPORATION VIETNAM PVS Hanoi Stock Exchange 555295524 PHUONG DONG PETROLEUM TOURISM JOINT STOCK COMPANY VIETNAM PDC Hanoi Stock Exchange 555265232 PP.PHARCO VIETNAM PPP Hanoi Stock Exchange 555431882 SAI GON VEGETABLE OIL JOINT STOCK COMPANY VIETNAM SGO Hanoi Stock Exchange 555304039 SAIGON HOTEL CORPORATION VIETNAM SGH Hanoi Stock Exchange 555295100 SIMCO SONGDA JOINT STOCK COMPANY VIETNAM SDA Hanoi Stock Exchange 555319875 SONG DA NO 11 JOINT
    [Show full text]
  • Factsheet.Pdf Published
    Lupus alpha Sustainable Smaller Euro Champions (A) For Marketing Purposes Only as of 31.08.2021 Portfolio Manager Investment Strategy The fund invests in the most promising small- and medium-size companies in Marcus Ratz Franz Führer Euroland. Based on a consistent bottom-up [A] approach, we select companies which are leading players in their specific market niche and hold a Partner, Partner, considerable market share therein. These quality titles often feature out- Portfolio- Portfolio- standing returns. Investing in the small & mid cap area means to operate in Management Management information inefficient markets that are not exhausted. This is the source for potential high increases in value. Environmental, social and governance (ESG) with Lupus alpha Asset with Lupus alpha Asset criteria are applied in the implementation of the strategy. Management AG since 2001 Management AG since 2001 The fund is categorized as an article 8 SFDR fund. [S] Fund Overview Performance (gross) [1]: 12 Month Period Class A Fund Benchmark Fund Benchmark ISIN 1 month 3.06% 3.27% 31.08.2020 - 31.08.2021 44.23% 41.49% LU0129232442 Benchmark 90 days 5.34% 5.17% 31.08.2019 - 31.08.2020 11.00% 2.41% Euro Stoxx® Total Market 3 years 42.16% 37.16% 31.08.2018 - 31.08.2019 -11.71% -5.97% Small Net Return Index 5 years 93.12% 70.99% 31.08.2017 - 31.08.2018 7.71% 4.36% Inception Date Year to date 23.16% 23.40% 31.08.2016 - 31.08.2017 26.12% 19.46% 22.10.2001 Since Inception 557.68% 437.78% 31.08.2015 - 31.08.2016 3.44% 1.85% Minimum Investment Since Inception p.a.
    [Show full text]
  • Software AG Infrastructure Administrator's Guide
    Software AG Infrastructure Administrator’s Guide Version 9.9 October 2015 This document applies to webMethods Product Suite Version 9.9 and to all subsequent releases. Specifications contained herein are subject to change and these changes will be reported in subsequent release notes or new editions. Copyright © 1999-2015 Software AG, Darmstadt, Germany and/or Software AG USA Inc., Reston, VA, USA, and/or its subsidiaries and/or its affiliates and/or their licensors. The name Software AG and all Software AG product names are either trademarks or registered trademarks of Software AG and/or Software AG USA Inc. and/or its subsidiaries and/or its affiliates and/or their licensors. Other company and product names mentioned herein may be trademarks of their respective owners. Detailed information on trademarks and patents owned by Software AG and/or its subsidiaries is located at hp://softwareag.com/licenses. Use of this software is subject to adherence to Software AG's licensing conditions and terms. These terms are part of the product documentation, located at hp://softwareag.com/licenses and/or in the root installation directory of the licensed product(s). This software may include portions of third-party products. For third-party copyright notices, license terms, additional rights or restrictions, please refer to "License Texts, Copyright Notices and Disclaimers of Third Party Products". For certain specific third-party license restrictions, please refer to section E of the Legal Notices available under "License Terms and Conditions for Use of Software AG Products / Copyright and Trademark Notices of Software AG Products". These documents are part of the product documentation, located at hp://softwareag.com/licenses and/or in the root installation directory of the licensed product(s).
    [Show full text]
  • Siemens Annual Report 2017
    Annual Report 2017 siemens.com Table of contents . A B C Combined Management Report Consolidated Financial Statements Additional Information A.1 p 2 B.1 p 58 C.1 p 126 Business and economic environment Consolidated Statements Responsibility Statement of Income A.2 p 9 C.2 p 127 Financial performance system B.2 p 59 Independent Auditor ʼs Report Consolidated Statements A.3 p 11 of Comprehensive Income C.3 p 133 Results of operations Report of the Supervisory Board B.3 p 60 A.4 p 17 Consolidated Statements C.4 p 137 Net assets position of Financial Position Corporate Governance B.4 p 61 A.5 p 18 C.5 p 147 Financial position Consolidated Statements Notes and forward- looking of Cash Flows statements A.6 p 22 B.5 p 62 Overall assessment of the economic position Consolidated Statements of Changes in Equity A.7 p 23 B.6 p 64 Non-financial matters Notes to Consolidated Financial ­Statements A.8 p 24 Report on expected developments and associated material opportunities and risks A.9 p 36 Siemens AG A.10 p 39 Compensation Report A.11 p 53 Takeover-relevant information . A Combined Management Report A.1 Business and economic environment A.1.1 The Siemens Group execution of large projects increasingly requires financing by the original equipment manufacturer (OEM), including equity partic- A.1.1.1 ORGANIZATION AND BASIS ipation, particularly in Latin America, the Middle East and Africa. OF PRESENTATION For the Division, this role is fulfilled by Financial Services, which We are a technology company with core activities in the fields of can offer customers a range of financing and equity options electrification, automation and digitalization, and activities in backed by domain know-how.
    [Show full text]
  • Aviation Forum Attendees 18/19
    Aviation Forum Attendees 18/19 Company Job Function . PMO and MBA Student 14bis Supply Tracking CEO and Co-founder 3D CONTECH GmbH & Co.KG Geschäftsführer 3D ICOM GmbH & Co. KG Vertriebsbeauftragter 3D ICOM GmbH & Co. KG Head of Engineering 3D Systems EVP, General Manager, Metals & Healthcare 3D Systems GmbH Direct Sales Manager Aerospace EMEA 3D Systems GmbH Sales Manager 3D Systems GmbH Direct Sales Manager 3D Systems GmbH Manager Metals Customer Innovation Center Leuven 3D Systems GmbH Direct Sales Manager 3D Printers 3D Systems GmbH Direct Sales Manager 3D.aero GmbH CAO 3D.aero GmbH Marketing Manager AAA GmbH President Aalberts Material Technology GmbH ACA Aerospace Consultancy Associates GmbH Geschäftsführer ACA Aerospace Consultancy Associates GmbH Partner ACA Aerospace Consultancy Associates GmbH Assistenz der Geschäftsführung ACA GmbH Senior Consultant ACA GmbH Partner ACA GmbH Partner ACA GmbH Partner ACA GmbH Partner Accenture Manging Director Accenture GmbH Senior Manager Accenture GmbH Senior Functional Strategy Executive Accenture GmbH A & D Lead Austria, Switzerland, Germany and Russia Accenture GmbH Consulting Manager Accenture Strategy Managing Director ACI Laser GmbH Technischer Vertrieb ACI Laser GmbH Technischer Vertrieb ACstyria Mobilitätscluster GmbH Project Manager Aerospace ACstyria Mobilitätscluster GmbH Head of Aerospace Actrans GmbH Partner Actrans GmbH Senior Consultant Actrans GmbH Partner Actrans GmbH Senior Consultant, Aerospace & Cyber Security Adamet Niemet CEO Adamet Niemet Procurement Specialist Adamet-Niemet
    [Show full text]